Michele Carbone, MD, PhD

Drs. Carbone and Yang at the University of Hawaii Cancer Center discovered a new inherited disease called BAP1 Cancer Syndrome. People with this condition are born with changes in the BAP1 gene, which puts them at higher risk for several cancers, especially mesothelioma—a deadly cancer of the chest and stomach lining often linked to asbestos. Whole families can be affected because the gene changes are passed down. Here’s the surprising part: even though BAP1 mutations cause cancer, the tumors in these patients often can’t spread easily. This means the cancer is less aggressive, and many patients live for years. Some have even been cured. Now, with support from the V-Foundation All-Star Award, Drs. Carbone and Yang are studying how these patients’ bodies fight cancer. Their goal is to use this discovery to help all cancer patients resist cancer spread, improve survival, and save lives. This research shows that understanding one family’s rare gene mutation could lead to big breakthroughs in cancer treatment for everyone.

Lang Wu, PhD

Pancreatic cancer is a deadly cancer. There are urgent needs to identify specific biomarkers in blood (proteins and metabolites) that  are  related to pancreatic cancer.  The increased understanding of risk factors  for  pancreatic  cancer  can  be  useful  to  develop  new  strategy  for predicting individual risk of developing this cancer. The proposed study using novel design and methods will help identify protein and  metabolite biomarkers in blood causally associated with pancreatic cancer risk. Knowledge generated by this project will help us to better understand the etiology of pancreatic cancer and lay a solid foundation for future efforts of risk prediction of this deadly cancer. The identification of  high-risk  individuals  can  be  useful  for  more  specific,  expensive,  and/or  invasive  tests  to  identify  disease  at  an early  stage  or  for  targeted  prevention to reduce disease risk.